10x Genomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,593	2,083	1,756	6,665	4,198	16,640
Market Cap Growth	220.00%	18.59%	-73.65%	58.77%	-74.77%	9.21%
Enterprise Value	3,135	1,633	1,436	6,360	3,851	16,128
Last Close Price	28.31	16.31	14.36	55.96	36.44	148.96
PS Ratio	5.63	3.24	2.88	10.77	8.13	33.93
PB Ratio	4.48	2.62	2.47	8.99	5.21	20.35
P/TBV Ratio	4.39	2.56	2.44	8.85	5.15	20.11
P/FCF Ratio	29.41	16.01	-	-	-	-
P/OCF Ratio	28.11	15.31	263.52	-	-	-
EV/Sales Ratio	4.91	2.54	2.35	10.28	7.46	32.88
EV/FCF Ratio	25.66	12.55	-	-	-	-
Debt / Equity Ratio	0.09	0.09	0.10	0.11	0.11	0.09
Debt / EBITDA Ratio	11.29	-	-	-	-	-
Debt / FCF Ratio	0.67	0.65	-	-	-	-
Net Debt / Equity Ratio	-0.56	-0.55	-0.44	-0.40	-0.42	-0.62
Net Debt / EBITDA Ratio	-63.59	25.57	2.06	1.32	2.50	21.11
Net Debt / FCF Ratio	-3.75	-3.37	54.25	4.60	2.04	4.13
Asset Turnover	0.62	0.66	0.65	0.62	0.50	0.50
Inventory Turnover	3.54	2.85	2.50	2.70	1.70	1.65
Quick Ratio	5.25	3.95	4.10	3.96	4.10	6.11
Current Ratio	5.90	4.46	4.97	4.69	4.85	6.77
Return on Equity (ROE)	-2.81%	-5.78%	-25.17%	-32.98%	-20.45%	-7.48%
Return on Assets (ROA)	-4.43%	-6.79%	-21.23%	-27.29%	-16.81%	-5.81%
Return on Invested Capital (ROIC)	-11.03%	-15.47%	-43.87%	-56.91%	-42.35%	-21.95%
Return on Capital Employed (ROCE)	-4.32%	-7.22%	-23.74%	-30.57%	-18.59%	-6.08%
FCF Yield	3.40%	6.25%	-	-	-	-
Buyback Yield / Dilution	-4.06%	-3.57%	-2.81%	-2.90%	-3.18%	-9.09%
Total Shareholder Return	-4.06%	-3.57%	-2.81%	-2.90%	-3.18%	-9.09%

SEC Filings: 10-K · 10-Q